Please provide your email address to receive an email when new articles are posted on . Between 2013 and 2025, use of non-aspirin antithrombotic therapy declined in total joint arthroplasty. The use ...

There are limited data from randomized trials evaluating the use of antithrombotic therapy in patients with atrial fibrillation and stable coronary artery disease. In a multicenter, open-label trial ...

Physicians should aim to use the least amount of antithrombotic therapy as possible in their patients undergoing TAVI, according to a new European consensus statement. In general, over the long term, ...

Because of rapidly changing guidelines in response to multiple clinical trials of new therapies, the management of antithrombotic agents for patients after an acute coronary syndrome is becoming ...

Patients with newly diagnosed psoriatic arthritis have a higher risk of CVD. Resuming antithrombotic therapy with in patients with atrial fibrillation and a serious gastrointestinal bleed results in ...

Antithrombotic therapy in patients with PAD can be a challenge to manage, but a new scientific statement uses patient vignettes to help clinicians link treatment options with patient characteristics ...

COVID-19 is associated with hypercoagulability and endothelial injury, which contribute to an increased risk of macro- and microvessel thrombosis, disease progression and death.1 Antithrombotic agents ...

Chicago, IL - New guidelines representing expert consensus on antithrombotic therapy have tried to lay to rest some controversial issues in treating heart and stroke patients. The merits of high- ...

The American Society of Regional Anesthesia and Pain Medicine (ASRA) has updated its evidence-based guidelines on regional anesthesia in patients on antithrombotic or thrombolytic therapy. The two ...

Hibernating bears, paralyzed humans, and pigs kept in small enclosures all avoid developing dangerous blood clots—venous thromboembolisms (VTEs)—despite being immobile for what can be extremely long ...